BR9912170A - Inaladores de dose medida pressurizados e formulações de aerossóis farmacêuticas - Google Patents
Inaladores de dose medida pressurizados e formulações de aerossóis farmacêuticasInfo
- Publication number
- BR9912170A BR9912170A BR9912170-0A BR9912170A BR9912170A BR 9912170 A BR9912170 A BR 9912170A BR 9912170 A BR9912170 A BR 9912170A BR 9912170 A BR9912170 A BR 9912170A
- Authority
- BR
- Brazil
- Prior art keywords
- dose inhalers
- metered dose
- aerosol formulations
- pressurized metered
- pharmaceutical aerosol
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
- A61K9/124—Aerosols; Foams characterised by the propellant
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Dispersion Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Otolaryngology (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Patente de Invenção: "INALADORES DE DOSE MEDIDA PRESSURIZADOS E FORMULAçõES DE AEROSSóIS FARMACêUTICAS". Fornecido são inaladores de dose medida pressurizados contendo formulações estáveis de uma droga <225>-agonista em suspensão ou solução. Também fornecidos são formulações de aerossóis adequadas para terapia de inalação contendo uma droga <225>-agonista em suspensão ou solução.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/099,779 US6451285B2 (en) | 1998-06-19 | 1998-06-19 | Suspension aerosol formulations containing formoterol fumarate and a fluoroalkane propellant |
PCT/US1999/013863 WO1999065460A2 (en) | 1998-06-19 | 1999-06-18 | Pressurized metered dose inhalers and pharmaceutical aerosol formulations comprising a beta-agonist |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9912170A true BR9912170A (pt) | 2001-10-23 |
Family
ID=22276581
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9912170-0A BR9912170A (pt) | 1998-06-19 | 1999-06-18 | Inaladores de dose medida pressurizados e formulações de aerossóis farmacêuticas |
Country Status (23)
Country | Link |
---|---|
US (2) | US6451285B2 (pt) |
EP (2) | EP1085856B1 (pt) |
JP (1) | JP2002518100A (pt) |
KR (1) | KR20010053025A (pt) |
CN (2) | CN1154477C (pt) |
AR (1) | AR018891A1 (pt) |
AT (2) | ATE260093T1 (pt) |
AU (1) | AU762927B2 (pt) |
BR (1) | BR9912170A (pt) |
CA (1) | CA2335303A1 (pt) |
CO (1) | CO5031245A1 (pt) |
DE (2) | DE69915144T2 (pt) |
DK (2) | DK1085856T3 (pt) |
ES (2) | ES2205848T3 (pt) |
HU (1) | HUP0102468A3 (pt) |
IL (1) | IL140340A0 (pt) |
NO (1) | NO20006466L (pt) |
PL (1) | PL345399A1 (pt) |
PT (2) | PT1085856E (pt) |
RU (1) | RU2214230C2 (pt) |
SK (1) | SK19442000A3 (pt) |
WO (1) | WO1999065460A2 (pt) |
ZA (1) | ZA200007455B (pt) |
Families Citing this family (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9616237D0 (en) | 1996-08-01 | 1996-09-11 | Norton Healthcare Ltd | Aerosol formulations |
US20010031244A1 (en) * | 1997-06-13 | 2001-10-18 | Chiesi Farmaceutici S.P.A. | Pharmaceutical aerosol composition |
US6451285B2 (en) * | 1998-06-19 | 2002-09-17 | Baker Norton Pharmaceuticals, Inc. | Suspension aerosol formulations containing formoterol fumarate and a fluoroalkane propellant |
DZ2947A1 (fr) * | 1998-11-25 | 2004-03-15 | Chiesi Farma Spa | Inhalateur à compteur de dose sous pression. |
US6315985B1 (en) * | 1999-06-18 | 2001-11-13 | 3M Innovative Properties Company | C-17/21 OH 20-ketosteroid solution aerosol products with enhanced chemical stability |
IT1313553B1 (it) | 1999-07-23 | 2002-09-09 | Chiesi Farma Spa | Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione. |
IT1317720B1 (it) * | 2000-01-07 | 2003-07-15 | Chiesi Farma Spa | Dispositivo per la somministrazione di aerosol dosati pressurizzati inpropellenti idrofluoroalcani. |
IT1317846B1 (it) * | 2000-02-22 | 2003-07-15 | Chiesi Farma Spa | Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva. |
IT1318514B1 (it) * | 2000-05-12 | 2003-08-27 | Chiesi Farma Spa | Formulazioni contenenti un farmaco glucocorticosteroide per iltrattamento di patologie broncopolmonari. |
BR0015884A (pt) | 2000-05-22 | 2003-07-08 | Chiesi Farma Spa | Formulações de soluções farmacêuticas estáveis para inaladores de dose medida pressurizados |
US20060257324A1 (en) | 2000-05-22 | 2006-11-16 | Chiesi Farmaceutici S.P.A. | Pharmaceutical solution formulations for pressurised metered dose inhalers |
US20030072717A1 (en) * | 2001-02-23 | 2003-04-17 | Vapotronics, Inc. | Inhalation device having an optimized air flow path |
ATE375142T1 (de) * | 2001-03-30 | 2007-10-15 | Jagotec Ag | Medizinische aerosolformulierungen |
PT1273292E (pt) * | 2001-07-02 | 2004-10-29 | Chiesi Farma Spa | Formulacao optimizada de tobramicina para aerossolizacao |
US20030178022A1 (en) * | 2001-12-21 | 2003-09-25 | Chiesi Farmaceutici S.P.A. | Pressurized metered dose inhaler (PMDI) actuators and medicinal aerosol solution formulation products comprising therse actuators |
DE10205087A1 (de) * | 2002-02-07 | 2003-08-21 | Pharmatech Gmbh | Cyclodextrine als Suspensionsstabilisatoren in druckverflüssigten Treibmitteln |
PT3384931T (pt) * | 2002-03-01 | 2019-09-26 | Chiesi Farm Spa | Formulaçâo superfina de formoterol |
GB0207899D0 (en) * | 2002-04-05 | 2002-05-15 | 3M Innovative Properties Co | Formoterol and cielesonide aerosol formulations |
US20050158248A1 (en) * | 2002-08-21 | 2005-07-21 | Xian-Ming Zeng | Method of preparing dry powder inhalation compositions |
ATE520405T1 (de) * | 2002-08-21 | 2011-09-15 | Norton Healthcare Ltd | Inhalationszusammensetzung |
GB0219511D0 (en) * | 2002-08-21 | 2002-10-02 | Norton Healthcare Ltd | Method of preparing dry powder inhalation compositions |
GB0323684D0 (en) * | 2003-10-09 | 2003-11-12 | Jagotec Ag | Improvements in or relating to organic compounds |
GB0323685D0 (en) * | 2003-10-09 | 2003-11-12 | Jagotec Ag | Improvements in or relating to organic compounds |
EP1595531A1 (en) | 2004-05-13 | 2005-11-16 | CHIESI FARMACEUTICI S.p.A. | Stable pharmaceutical solution formulations for pressurized metered dose inhalers |
WO2007008427A2 (en) * | 2005-07-08 | 2007-01-18 | Xemplar Pharmaceuticals, Llc | Aerosol compositions and methods |
US8367734B1 (en) | 2005-08-11 | 2013-02-05 | Amphastar Pharmaceuticals Inc. | Stable epinephrine suspension formulation with high inhalation delivery efficiency |
US8815258B2 (en) | 2009-05-29 | 2014-08-26 | Pearl Therapeutics, Inc. | Compositions, methods and systems for respiratory delivery of two or more active agents |
TWI792140B (zh) * | 2009-05-29 | 2023-02-11 | 美商沛爾醫療股份有限公司 | 用於經由呼吸道遞送二或更多種活性藥劑的組成物、方法與系統 |
GB0918149D0 (en) | 2009-10-16 | 2009-12-02 | Jagotec Ag | Improved medicinal aerosol formulation |
EP2512438B1 (en) | 2009-12-16 | 2017-01-25 | 3M Innovative Properties Company | Formulations and methods for controlling mdi particle size delivery |
GB201108039D0 (en) | 2011-05-13 | 2011-06-29 | Mexichem Amanco Holding Sa | Compositions |
GB201117619D0 (en) | 2011-10-12 | 2011-11-23 | Mexichem Amanco Holding Sa | Compositions |
GB201117621D0 (en) | 2011-10-12 | 2011-11-23 | Mexichem Amanco Holding Sa | Compositions |
TR201902687T4 (tr) | 2013-03-15 | 2019-03-21 | Pearl Therapeutics Inc | İri parçacıklı kristal malzemelerin koşullandırılması için yöntemler ve sistemler. |
GB201306984D0 (en) | 2013-04-17 | 2013-05-29 | Mexichem Amanco Holding Sa | Composition |
CN108289843B (zh) | 2015-12-04 | 2021-08-17 | 墨西哥氟石股份公司 | 药物组合物 |
PE20191043A1 (es) | 2016-09-19 | 2019-08-06 | Mexichem Fluor Sa De Cv | Composicion farmaceutica |
MX2019003105A (es) | 2016-09-19 | 2019-08-01 | Mexichem Fluor Sa De Cv | Composicion farmaceutica. |
CN109715148A (zh) | 2016-09-19 | 2019-05-03 | 墨西哥氟石股份公司 | 药物组合物 |
CN109464429B (zh) * | 2018-12-13 | 2021-04-27 | 上海方予健康医药科技有限公司 | 一种吸入压力定量气雾剂药物组合物及其制备方法 |
Family Cites Families (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE556587A (pt) | 1957-01-31 | 1957-04-11 | ||
NL7708731A (nl) | 1976-08-13 | 1978-02-15 | Montedison Spa | Werkwijze voor de bereiding van nieuwe drijf- middelsamenstellingen voor aerosolen. |
US5776434A (en) * | 1988-12-06 | 1998-07-07 | Riker Laboratories, Inc. | Medicinal aerosol formulations |
US5225183A (en) | 1988-12-06 | 1993-07-06 | Riker Laboratories, Inc. | Medicinal aerosol formulations |
IL97065A (en) | 1990-02-02 | 1994-01-25 | Fisons Plc | Repellent preparations for aerosol |
AU8055691A (en) | 1990-06-29 | 1992-01-23 | Fisons Plc | Pressurised aerosol compositions |
MX9203481A (es) | 1990-10-18 | 1992-07-01 | Minnesota Mining & Mfg | Formulaciones. |
DK0553298T3 (da) | 1990-10-18 | 1995-04-18 | Minnesota Mining & Mfg | Aerosolformulering omfattende beclomethason-17,21-dipropionat |
US5190029A (en) | 1991-02-14 | 1993-03-02 | Virginia Commonwealth University | Formulation for delivery of drugs by metered dose inhalers with reduced or no chlorofluorocarbon content |
EP0504112A3 (en) | 1991-03-14 | 1993-04-21 | Ciba-Geigy Ag | Pharmaceutical aerosol formulations |
AU2178392A (en) | 1991-06-12 | 1993-01-12 | Minnesota Mining And Manufacturing Company | Albuterol sulfate suspension aerosol formulations |
DE4123663A1 (de) | 1991-07-17 | 1993-01-21 | Schwabe Willmar Gmbh & Co | Aerosol-zubereitung und verwendung eines treibmittels dafuer |
AU663906B2 (en) * | 1991-12-12 | 1995-10-26 | Glaxo Group Limited | Medicaments |
US5736124A (en) * | 1991-12-12 | 1998-04-07 | Glaxo Group Limited | Aerosol formulations containing P134a and particulate medicament |
JP3908269B2 (ja) | 1991-12-18 | 2007-04-25 | スリーエム カンパニー | 懸濁エアゾール製剤 |
SG48301A1 (en) | 1991-12-18 | 1998-04-17 | Astra Ab | New combination |
DK0550031T3 (da) | 1991-12-31 | 1996-08-26 | Solvay | Medicinsk aerosolformulering |
US5492688A (en) | 1993-04-28 | 1996-02-20 | The Center For Innovative Technology | Metered dose inhaler fomulations which include the ozone-friendly propellant HFC 134a and a pharmaceutically acceptable suspending, solubilizing, wetting, emulsifying or lubricating agent |
US5508023A (en) | 1994-04-11 | 1996-04-16 | The Center For Innovative Technology | Pharmaceutically acceptable agents for solubilizing, wetting, emulsifying, or lubricating in metered dose inhaler formulations which use HFC-227 propellant |
CZ288146B6 (en) | 1994-12-22 | 2001-05-16 | Astra Ab | Pharmaceutical aerosol preparation, process of its preparation and use |
DE4446891A1 (de) * | 1994-12-27 | 1996-07-04 | Falk Pharma Gmbh | Stabile wäßrige Budesonid-Lösung |
GB9612297D0 (en) | 1996-06-11 | 1996-08-14 | Minnesota Mining & Mfg | Medicinal aerosol formulations |
GB9616237D0 (en) * | 1996-08-01 | 1996-09-11 | Norton Healthcare Ltd | Aerosol formulations |
US6039932A (en) * | 1996-09-27 | 2000-03-21 | 3M Innovative Properties Company | Medicinal inhalation aerosol formulations containing budesonide |
SE9603669D0 (sv) | 1996-10-08 | 1996-10-08 | Astra Ab | New combination |
EP1011646B1 (en) | 1996-12-04 | 2005-08-17 | Link Products Limited | Pharmaceutical compositions and devices for their administration |
US6451285B2 (en) * | 1998-06-19 | 2002-09-17 | Baker Norton Pharmaceuticals, Inc. | Suspension aerosol formulations containing formoterol fumarate and a fluoroalkane propellant |
US6004537A (en) * | 1998-12-18 | 1999-12-21 | Baker Norton Pharmaceuticals, Inc. | Pharmaceutical solution aerosol formulations containing fluoroalkanes, budesonide and formoterol |
-
1998
- 1998-06-19 US US09/099,779 patent/US6451285B2/en not_active Expired - Fee Related
-
1999
- 1999-06-18 EP EP99931837A patent/EP1085856B1/en not_active Expired - Lifetime
- 1999-06-18 CA CA002335303A patent/CA2335303A1/en not_active Abandoned
- 1999-06-18 WO PCT/US1999/013863 patent/WO1999065460A2/en not_active Application Discontinuation
- 1999-06-18 AT AT02026980T patent/ATE260093T1/de not_active IP Right Cessation
- 1999-06-18 ES ES99931837T patent/ES2205848T3/es not_active Expired - Lifetime
- 1999-06-18 PT PT99931837T patent/PT1085856E/pt unknown
- 1999-06-18 DK DK99931837T patent/DK1085856T3/da active
- 1999-06-18 CN CNB998088641A patent/CN1154477C/zh not_active Expired - Fee Related
- 1999-06-18 PT PT02026980T patent/PT1306082E/pt unknown
- 1999-06-18 KR KR1020007014438A patent/KR20010053025A/ko not_active Application Discontinuation
- 1999-06-18 AR ARP990102934A patent/AR018891A1/es not_active Application Discontinuation
- 1999-06-18 RU RU2001101889/14A patent/RU2214230C2/ru not_active IP Right Cessation
- 1999-06-18 DK DK02026980T patent/DK1306082T3/da active
- 1999-06-18 DE DE69915144T patent/DE69915144T2/de not_active Expired - Fee Related
- 1999-06-18 AU AU48259/99A patent/AU762927B2/en not_active Ceased
- 1999-06-18 PL PL99345399A patent/PL345399A1/xx unknown
- 1999-06-18 DE DE69911602T patent/DE69911602T2/de not_active Expired - Fee Related
- 1999-06-18 BR BR9912170-0A patent/BR9912170A/pt not_active IP Right Cessation
- 1999-06-18 HU HU0102468A patent/HUP0102468A3/hu unknown
- 1999-06-18 AT AT99931837T patent/ATE250409T1/de not_active IP Right Cessation
- 1999-06-18 EP EP02026980A patent/EP1306082B1/en not_active Expired - Lifetime
- 1999-06-18 JP JP2000554340A patent/JP2002518100A/ja active Pending
- 1999-06-18 ES ES02026980T patent/ES2215153T3/es not_active Expired - Lifetime
- 1999-06-18 CN CNA2003101046076A patent/CN1522692A/zh active Pending
- 1999-06-18 SK SK1944-2000A patent/SK19442000A3/sk unknown
- 1999-06-18 IL IL14034099A patent/IL140340A0/xx unknown
- 1999-06-21 CO CO99038537A patent/CO5031245A1/es unknown
-
2000
- 2000-12-13 ZA ZA200007455A patent/ZA200007455B/en unknown
- 2000-12-18 NO NO20006466A patent/NO20006466L/no not_active Application Discontinuation
-
2002
- 2002-07-02 US US10/190,094 patent/US20030077230A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9912170A (pt) | Inaladores de dose medida pressurizados e formulações de aerossóis farmacêuticas | |
HUS1800032I1 (hu) | Gyógyászati célú stabil aeroszol összetétel, inhalátor az aeroszol pontos adagolásához és eljárás ennek feltöltésére | |
YU56600A (sh) | Uređaj za raznošenje aktivnog agensa u pluća pacijenta | |
YU80000A (sh) | Farmaceutske formulacije za aerosolove sa dve ili više aktivnih supstanci | |
JO2381B1 (en) | Formulation containing anticholinergic drug for the treatment of chronic obstructive pulmonary disease | |
MY131733A (en) | Aerosol drug formulations | |
ATE205099T1 (de) | Inhalator zur verabreichung von arzneimitteln aus blisterverpackungen | |
IS4178A (is) | Lyfjablanda til innöndunar sem inniheldur insúlín | |
PT1173243E (pt) | Inalador de po para um medicamento combinado | |
MXPA01006377A (es) | Administracion pulmonar de medicamento. | |
ZA200100569B (en) | Medicinal aerosol formulations. | |
BG105391A (en) | Storable concentrate of formoterol active substance | |
DE69716469T2 (de) | Pharmazeutische zusammensetzung enthaltend ein osteogenese foerderndes mittel und ein polyethylen-glycol | |
BR9812553A (pt) | Formulação medicamentosa com liberação de substância ativa controlada | |
ATE271852T1 (de) | Verbesserte inhalationspräparate | |
WO1999050239A3 (fr) | Nouveaux composes heteroethynylenes et compositions pharmaceutiques et cosmetiques les contenant | |
TW374085B (en) | Novel piperidine derivatives, their preparation, pharmaceutical formulation and medical use | |
TH29519B (th) | สูตรผสมทางเภสัชศาสตร์ที่เสถียรชนิดใหม่สำหรับการผลิตละอองลอยที่ไม่มีแก๊สผลักดัน |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 7A E 8A ANUIDADES |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1922 DE 06/11/2007. |